内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-19 · 构建时间： 2026-10-19 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

EyePoint, Inc.

EYPT · Nasdaq · CIK 0001314102 · Healthcare · Biotechnology

内部人信号

当前没有活跃买入信号

1 qualifying P purchase group
当前 180 天评分窗口

11 同一窗口内观察到的 Form 4 交易行
2 sales · 8 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2026-08-18 · Zaderej Karen L. · $52.3K

为什么没有活跃信号？

买入活动存在
近期买入1 qualifying line group(s)
近期卖出较低
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数？

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。

卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。

买方广度与集中度

合资格买方1
买入集中度100%最大买方： Zaderej Karen L. · $52.3K
聚集买入 · 15天1 insider峰值活动： 2026-08-18–2026-08-18

Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Elston GeorgeChief Financial Officer
○○○○
Duker Jay S.President and CEO
○○
Ribeiro RamiroChief Medical Officer
○▼
Zaderej Karen L.Director
●
● 买入▼ 卖出○ 其他

—

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-08-18 · Zaderej Karen L..

近期 Form 4 活动

2买入
11卖出
31其他 Form 4 交易行
24SEC 申报 · 365天
买入1 qualifying P line(s) · 180 days
卖出2 sale line(s) · 仅供背景
其他8 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
20,788,240
上期报告
19,809,561
日均成交量
3,863,442
回补天数
5.4

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-08-18Zaderej Karen L.买入 (P)Common Stock10,600USD 4.93USD 52,258SEC 申报 ↗
2026-03-16Duker Jay S.买入 (P)Common Stock1,500USD 13.15USD 19,725SEC 申报 ↗
2025-05-19Zaderej Karen L.买入 (P)Common Stock5,000USD 5.99USD 29,950SEC 申报 ↗
2025-05-16Zaderej Karen L.买入 (P)Common Stock5,000USD 5.81USD 29,050SEC 申报 ↗
2025-05-15Zaderej Karen L.买入 (P)Common Stock5,000USD 5.47USD 27,350SEC 申报 ↗
2025-05-14Zaderej Karen L.买入 (P)Common Stock5,000USD 5.42USD 27,100SEC 申报 ↗
2024-08-21ANDO GORAN买入 (P)Common Stock5,000USD 7.95USD 39,750SEC 申报 ↗
2024-08-20DICICCO WENDY F买入 (P)Common Stock2,567USD 7.79USD 19,997SEC 申报 ↗
2024-08-19Zaderej Karen L.买入 (P)Common Stock12,500USD 7.98USD 99,750SEC 申报 ↗
2024-08-16Lurker Nancy买入 (P)Common Stock3,173USD 7.88USD 25,003SEC 申报 ↗
2024-05-06Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP买入 (P)Common Stock850,000USD 11.86USD 10,081,721SEC 申报 ↗
2024-04-18Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP买入 (P)Common Stock581,765USD 18.03USD 10,489,446SEC 申报 ↗
2024-01-11Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP买入 (P)Common Stock750,000USD 19.75USD 14,812,500SEC 申报 ↗
2024-01-09Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP买入 (P)Common Stock105,000USD 21.32USD 2,238,600SEC 申报 ↗
2023-12-08Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP买入 (P)Common Stock588,235USD 17.00USD 9,999,995SEC 申报 ↗

Form 4 申报证据

44 transaction lines in the latest 365-day window; 310 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-08-20Elston GeorgeJ (J)Common Stock5,000USD 0.00USD 0SEC 申报 ↗
2026-08-20Elston George赠与 (G)Common Stock64,953USD 0.00USD 0SEC 申报 ↗
2026-08-18Zaderej Karen L.买入 (P)Common Stock10,600USD 4.93USD 52,258SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-08-20Elston GeorgeJ (J)Common Stock5,000USD 0.00USD 0SEC 申报 ↗
2026-08-20Elston George赠与 (G)Common Stock64,953USD 0.00USD 0SEC 申报 ↗
2026-08-18Zaderej Karen L.买入 (P)Common Stock10,600USD 4.93USD 52,258SEC 申报 ↗
2026-07-10Duker Jay S.期权行权／转换 (M)Common Stock16,667USD 0.00USD 0SEC 申报 ↗
2026-07-10Duker Jay S.代扣税 (F)Common Stock8,059USD 14.72USD 118,628SEC 申报 ↗
2026-06-30Ribeiro Ramiro卖出 (S)Common Stock4,875USD 15.01USD 73,174SEC 申报 ↗
2026-06-30Ribeiro Ramiro期权行权／转换 (M)Common Stock4,875USD 8.26USD 40,268SEC 申报 ↗
2026-05-25Elston George期权行权／转换 (M)Common Stock7,500USD 0.00USD 0SEC 申报 ↗
2026-05-25Elston George代扣税 (F)Common Stock3,627USD 12.93USD 46,897SEC 申报 ↗
2026-04-17Ribeiro Ramiro卖出 (S)Common Stock2,437USD 15.00USD 36,555SEC 申报 ↗
2026-04-17Ribeiro Ramiro期权行权／转换 (M)Common Stock2,437USD 8.26USD 20,130SEC 申报 ↗
2026-03-23Duker Jay S.J (J)Common Stock76,766USD 13.11USD 1,006,402SEC 申报 ↗
2026-03-16Duker Jay S.买入 (P)Common Stock1,500USD 13.15USD 19,725SEC 申报 ↗
2026-03-04Ribeiro Ramiro卖出 (S)Common Stock2,438USD 17.87USD 43,567SEC 申报 ↗
2026-03-04Ribeiro Ramiro期权行权／转换 (M)Common Stock2,438USD 8.26USD 20,138SEC 申报 ↗
2026-03-02Elston George赠与 (G)Common Stock5,000USD 0.00USD 0SEC 申报 ↗
2026-02-17Ribeiro Ramiro卖出 (S)Common Stock2,437USD 15.00USD 36,555SEC 申报 ↗
2026-02-17Ribeiro Ramiro期权行权／转换 (M)Common Stock2,437USD 8.26USD 20,130SEC 申报 ↗
2026-01-06Lurker Nancy期权行权／转换 (M)Common Stock75,133USD 0.00USD 0SEC 申报 ↗
2026-01-06Elston George期权行权／转换 (M)Common Stock15,285USD 0.00USD 0SEC 申报 ↗
2026-01-06Elston George代扣税 (F)Common Stock4,487USD 16.86USD 75,651SEC 申报 ↗
2026-01-06Duker Jay S.期权行权／转换 (M)Common Stock20,793USD 0.00USD 0SEC 申报 ↗
2026-01-06Duker Jay S.代扣税 (F)Common Stock10,054USD 16.86USD 169,510SEC 申报 ↗
2026-01-05Ribeiro Ramiro卖出 (S)Common Stock42,544USD 17.10USD 727,502SEC 申报 ↗
2026-01-05Ribeiro Ramiro期权行权／转换 (M)Common Stock29,250USD 8.26USD 241,605SEC 申报 ↗
2026-01-05Lurker Nancy期权行权／转换 (M)Common Stock12,666USD 0.00USD 0SEC 申报 ↗
2026-01-05Elston George期权行权／转换 (M)Common Stock15,000USD 0.00USD 0SEC 申报 ↗
2026-01-05Elston George代扣税 (F)Common Stock4,403USD 17.43USD 76,744SEC 申报 ↗
2026-01-05Duker Jay S.期权行权／转换 (M)Common Stock30,000USD 0.00USD 0SEC 申报 ↗
2026-01-05Duker Jay S.代扣税 (F)Common Stock14,505USD 17.43USD 252,822SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-19
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码EYPT
CIK0001314102
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC3826 Laboratory Analytical Instruments
交易所Nasdaq

数据覆盖

本地 Form 4 历史310 transaction lines from 2020-02-21 to 2026-08-20
39 P purchase lines · 67 S sale lines · 204 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.